Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Peptide & Protein Research   Volumes    Volume 7 
Abstract
Programmed cell death 4 (Pdcd4) – a potential target for new approaches in cancer therapy
B. Lankat-Buttgereit, R. Göke
Pages: 63 - 66
Number of pages: 4
Current Topics in Peptide & Protein Research
Volume 7 

Copyright © 2005 Research Trends. All rights reserved

ABSTRACT

During investigation of the mechanisms of programmed cell death, Pdcd4 (programmed cell death 4) was identified as one gene being up-regulated during apoptosis. While the role of Pdcd4 during apoptosis is still unclear, there is emerging evidence that Pdcd4 acts as a tumour suppressor. So far, there is little knowledge about the signal transduction mechanisms of Pdcd4. However, several reports indicate that Pdcd4 acts on different signalling pathways: Pdcd4 interacts via a conserved MA-3 domain with the translation factor eIF4A thereby inhibiting protein synthesis. Furthermore, Pdcd4 reduces the transactivation of the transcription factor complex AP-1, which is involved in neoplastic transformation. Additionally, Pdcd4 seems to possess a RNA binding activity. Because of its participation in apoptosis and tumour suppression Pdcd4 might represent a potential target for new therapeutic strategies in cancer treatment. This review summarizes the current knowledge about Pdcd4.

Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms